Skip to main content
. 2017 Oct 16;7:13201. doi: 10.1038/s41598-017-13501-1

Table 1.

Cross tabulation of all analyzed patients and healthy volunteers by the number of csMVP-positive CTCs. The number 2.32 is the median number of csMVP-positive CTCs per milliliter (ml) in patients with HCC.

Disease groups Case No. No. of csMVP(+) CTC in blood
Low (<2.32/ml) High (≥2.32/ml)
Non-neoplastic group* (n = 12) 12 (100%) 0 (0%)
Healthy control (n = 10) 10 (100%) 0 (0%)
Acute hepatitis (n = 2) 2 (100%) 0 (0%)
Primary HCC* (n = 53) 28 (52.8%) 25 (47.2%)
Secondary disease* (n = 19) 4 (21.1%) 15 (78.9%)
Recurrent HCC (n = 5) 1 (20%) 4 (80%)
Metastases to liver (n = 14) 3 (21.4%) 11 (78.6%)

* p < 0.001 by χ 2-test: non-neoplastic vs. primary HCC, p = 0.002; primary HCC vs. metastatic, p = 0.017; non-neoplastic vs. metastatic, p < 0.001 by χ2-test.